Shams Arifeen
Telix Pharmaceuticals Limited, NSW, Australia
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
A qualitative research to understand public perception of personalised cancer medicine (PCM) and its application in treatment of advanced lung cancer (#341)
3:00 PM
Shams Arifeen
Posters 2